Halank, M., & Meyer, F. J. (2017). Riociguat for pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: Results from a phase II long-term extension study. Respiratory medicine, 128, . https://doi.org/10.1016/j.rmed.2017.05.008
Chicago-Zitierstil (17. Ausg.)Halank, Michael, und Franz Joachim Meyer. "Riociguat for Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension: Results from a Phase II Long-term Extension Study." Respiratory Medicine 128 (2017). https://doi.org/10.1016/j.rmed.2017.05.008.
MLA-Zitierstil (9. Ausg.)Halank, Michael, und Franz Joachim Meyer. "Riociguat for Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension: Results from a Phase II Long-term Extension Study." Respiratory Medicine, vol. 128, 2017, https://doi.org/10.1016/j.rmed.2017.05.008.